Gandhinagar, India | New Jersey, USA | Amsterdam, Europe — [15-07-2025]
FTI Incorporation, an innovation-driven forensic and pharmaceutical technology firm, is proud to announce its latest advancements in inspection technologies, firmly establishing its position as a global leader in USP 1790 Particles for visual inspection and vial defect detection USA. With a growing international footprint and a relentless focus on quality assurance, FTI continues to raise the bar in visual inspection systems for pharmaceutical packaging and injectable products.
As regulatory expectations become increasingly stringent, pharmaceutical manufacturers around the world are turning to advanced solutions to ensure compliance, reduce risk, and maintain consumer safety. FTI Incorporation is meeting this demand by offering comprehensive, high-accuracy visual inspection systems aligned with global pharmacopeial standards such as the United States Pharmacopeia (USP), particularly USP 1790.
Empowering Visual Inspection with USP 1790 Compliance
Visual inspection remains a critical quality control step in the production of sterile injectable drugs. With the introduction of USP 1790 Particles for visual inspection, the industry has a clear and detailed guideline for implementing and validating particulate matter inspection procedures. FTI Incorporation is at the forefront of helping pharmaceutical companies meet this standard with confidence.
FTI’s systems integrate advanced imaging technology with AI-powered software to detect visible and sub-visible particles with unmatched precision. The company’s automated visual inspection platforms are designed to enhance human inspection capabilities, reduce operator bias, and provide traceable and auditable inspection results that meet regulatory expectations.
“Our goal is not just compliance but excellence,” said a senior representative from FTI Incorporation. “By aligning our technologies with USP 1790 Particles for visual inspection, we are helping companies transition from traditional inspection methods to advanced, validated systems that boost efficiency, reliability, and patient safety.”
FTI also provides validation services, training programs, and consultancy support to pharmaceutical firms looking to align their quality systems with USP and FDA expectations. These services are especially valuable for facilities undergoing regulatory audits or preparing for product approval.
Leading the Charge in Vial Defect Detection USA
FTI Incorporation has made significant strides in expanding its market presence in North America, particularly with its proprietary vial defect detection USA solutions. Vial integrity is a non-negotiable factor in injectable drug safety. Even the smallest vial defect — whether it’s a microcrack, chipped edge, or improperly sealed stopper — can lead to sterility breach, contamination, and product recall.
To counter this risk, FTI has developed high-speed vial defect detection systems specifically tailored for U.S. manufacturers and contract development and manufacturing organizations (CDMOs). These systems utilize a combination of high-resolution vision sensors, infrared imaging, and AI-driven anomaly detection to inspect every vial, from base to neck, in real time.
“In the U.S., where the pharmaceutical supply chain demands the highest levels of quality assurance, our vial defect detection USA solutions are a game-changer,” said the Head of U.S. Operations at FTI. “We’ve designed our systems to detect defects that even experienced human inspectors can miss — ensuring zero-defect packaging before products reach patients.”
These technologies are already being adopted by top-tier U.S. pharmaceutical companies for both clinical and commercial vial packaging lines. From injectable vaccines to oncology drugs, FTI’s vial inspection solutions are helping manufacturers protect product integrity and brand trust.
Global Presence with Local Expertise
With its roots in India and operational offices in the USA and Europe, FTI Incorporation is uniquely positioned to serve clients across different regulatory environments and market needs. The company’s innovation lab is based in Gandhinagar, Gujarat, India, where it operates under the incubation of the National Forensic Sciences University (NFSU) — a government institution dedicated to advancing forensic and analytical sciences.
This academic and technological ecosystem allows FTI to remain on the cutting edge of research, validation, and compliance innovation. From its U.S. office in Randolph, New Jersey, the company provides client support, system installations, and service agreements throughout North America. Similarly, its Europe office in Amsterdam enables it to serve EU pharmaceutical manufacturers with timely support and local expertise.
Partnerships, Innovation, and the Road Ahead
FTI Incorporation is actively engaging in research collaborations with pharmaceutical companies, regulatory consultants, and academic institutions to push the boundaries of visual inspection technology. The company is currently developing next-generation AI tools that can learn from previous inspection datasets and evolve inspection accuracy over time — leading to smarter and faster decision-making.
With regulatory compliance becoming increasingly globalized, the need for harmonized, automated, and validated inspection technologies is greater than ever. FTI’s innovation roadmap includes fully integrated inspection and data reporting modules, enabling pharmaceutical companies to maintain a digital audit trail and minimize the burden of manual record-keeping.
Additionally, the company is expanding its training programs for pharmaceutical quality assurance professionals, with specific focus on USP 1790 Particles for visual inspection compliance, practical inspection setup, and defect categorization protocols. These educational initiatives aim to build industry-wide capacity and ensure that quality remains a shared responsibility.
Contact Information
For all inquiries, partnerships, and support, please reach out to us:
Phone:
📞 +91 8200487148 | +91 9638344845
Email:
✉️ [email protected] | [email protected]
Website:
Head Office – India:
Forensic Technological Innovation
Incubated at National Forensic Sciences University
Sector 9, Gandhinagar, Gujarat – 382007
India
USA Office:
58 Albert Ct
City: Randolph
State: New Jersey
Zip code: 07869
USA
Europe Office:
Jisperveldstaart
1024AT
Amsterdam
Netherlands
About FTI Incorporation
FTI Incorporation is a leading provider of advanced visual inspection, vial defect detection, and forensic quality control systems for the pharmaceutical and biotech sectors. Founded with the mission to blend forensic science with industrial precision, FTI delivers validated, regulatory-compliant, and globally trusted solutions. With expertise spanning the U.S., Europe, and Asia, FTI Incorporation is redefining quality standards for the pharmaceutical industry.
Comments